Telix Pharmaceuticals TLX
NASDAQ TLX
$10.78 -0.19 (-1.73%)
As of: Oct 1, 2026 · 2:13 PM EDT

Telix Pharmaceuticals (TLX) Shares Outstanding (2023 - 2026)

Updated

Telix Pharmaceuticals' Shares Outstanding was 337.88 million in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Shares Outstanding (2023 - 2026) Analysis & Trends

From the quarter ended Dec 31, 2023 onward, Telix Pharmaceuticals has reported Shares Outstanding for 4 quarters.

  • Shares Outstanding has now increased for three consecutive years, with a three-year compound annual growth rate of 2.8% (years ended Dec 2022 to Dec 2025).
  • In earlier years, Shares Outstanding was 331.23 million in the year ended Dec 31, 2024 (+3.8%), 319.18 million in the year ended Dec 31, 2023 (+2.7%) and 310.64 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Telix Pharmaceuticals 3.72 Bn 2.66 Bn - 337.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 337.88 Mn
Dec 31, 2025 337.88 Mn
Dec 31, 2024 331.23 Mn
Dec 31, 2023 319.18 Mn
API Access

Telix Pharmaceuticals Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TLX&period=max&api_key=YOUR_API_KEY